The challenges of psychopharmacogenetics.
Catalano
M
M
Istituto di Ricovero e Cura a Carattere Scientifico H San Raffaele, DSNP, Milan, Italy. catalano.marco@hsr.it
D003863:Depression / Q000188:drug therapy / Q000235:genetics; D006801:Humans; D008995:Monoamine Oxidase / Q000235:genetics; D016584:Panic Disorder / Q000188:drug therapy / Q000201:enzymology / Q000235:genetics; D010597:Pharmacogenetics / Q000639:trends; D011401:Promoter Regions, Genetic / Q000235:genetics; D011600:Psychopharmacology / Q000639:trends; D011619:Psychotropic Drugs / Q000378:metabolism / Q000493:pharmacokinetics / Q000627:therapeutic use; D017448:Receptors, Dopamine D2 / Q000235:genetics / Q000502:physiology; D050638:Receptors, Dopamine D4; D011985:Receptors, Serotonin / Q000235:genetics
C493599:DRD4 protein, human; D011619:Psychotropic Drugs; D017448:Receptors, Dopamine D2; D011985:Receptors, Serotonin; D050638:Receptors, Dopamine D4; D008995:Monoamine Oxidase